Company intelligence / Profile preview

Norgen Biotek

Thorold, Ontario, Canada

Ownership: Private
Development stage: Commercial

Overview

Norgen Biotek has developed a proprietary resin-based platform enabling efficient isolation of nucleic acids and proteins from diverse samples. Their products are widely used by academic labs and industry researchers globally. The company holds over thirty-five issued or pending patents related to their technologies. No clinical results as they do not develop drugs or diagnostics themselves.

Modalities: DeviceReagent/Kit
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Norgen Biotek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norgen Biotek.

Explore the full profile